(Q35090292)

6 August 2017

title

Assessment of cognitive and motor deficits in a marmoset model of stroke (English)

1 reference

6 August 2017

author name string

Jonathan W B Marshall

series ordinal

1

1 reference

6 August 2017

Rosalind M Ridley

series ordinal

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

44

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

153-160

1 reference

Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Temporary Occlusion of the Middle Cerebral Artery in the Monkey: Clinical and Pathological Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Experimental acute thrombotic stroke in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Cerebral infarction. Evolution of histopathological changes after occlusion of a middle cerebral artery in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Reversible middle cerebral artery occlusion without craniectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

NXY-059, a free radical--trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Assessment of functional impairment following permanent middle cerebral artery occlusion in a non-human primate species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Clinical experience with excitatory amino acid antagonist drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

Animal models of stroke: are they relevant to human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR.44.2.153

21 January 2018

Identifiers

DOI

10.1093/ILAR.44.2.153

1 reference

6 August 2017

1 reference